| Line Item | 2024-12-27 | Y/Y |
|---|---|---|
| Revenue | $2.10B | +20.9% |
| Cost of Revenue | $1.74B | +19.5% |
| Gross Profit | $356.3M | +28.5% |
| R&D Expense | $28.3M | +0.0% |
| SG&A Expense | $179.5M | +10.8% |
| Operating Income | $91.2M | +159.1% |
| Pre-tax Income | $67.2M | +694.7% |
| Income Tax | $32.7M | +200.0% |
| Net Income | $23.7M |
| Line Item | 2024-12-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $313.9M | +2.2% |
| Accounts Receivable | $241.1M | +33.4% |
| Inventory | $381.0M | +1.7% |
| Current Assets | $970.1M | +8.6% |
| Total Assets | $1.92B | +2.8% |
| Current Liabilities | $335.6M | +8.3% |
| Long-term Debt | $499.7M | — |
| Line Item | 2024-12-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $65.0M | -52.2% |
| Capital Expenditures | $63.5M | -16.2% |
| Investing Cash Flow | -$63.5M | +47.0% |
| Financing Cash Flow | $9.8M | +114.0% |
| Free Cash Flow | $1.5M | -97.5% |
| +176.2% |
| EPS (Basic) | $0.53 | +175.7% |
| EPS (Diluted) | $0.52 | +174.3% |
| Total Liabilities |
| $984.1M |
| +1.4% |
| Stockholders' Equity | $873.6M | +4.1% |